Correlation Between Intel and Travere Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Intel and Travere Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Intel and Travere Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Intel and Travere Therapeutics, you can compare the effects of market volatilities on Intel and Travere Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Intel with a short position of Travere Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Intel and Travere Therapeutics.

Diversification Opportunities for Intel and Travere Therapeutics

0.77
  Correlation Coefficient

Poor diversification

The 3 months correlation between Intel and Travere is 0.77. Overlapping area represents the amount of risk that can be diversified away by holding Intel and Travere Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Travere Therapeutics and Intel is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Intel are associated (or correlated) with Travere Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Travere Therapeutics has no effect on the direction of Intel i.e., Intel and Travere Therapeutics go up and down completely randomly.

Pair Corralation between Intel and Travere Therapeutics

Given the investment horizon of 90 days Intel is expected to generate 12.15 times less return on investment than Travere Therapeutics. But when comparing it to its historical volatility, Intel is 1.61 times less risky than Travere Therapeutics. It trades about 0.0 of its potential returns per unit of risk. Travere Therapeutics is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  1,969  in Travere Therapeutics on August 29, 2024 and sell it today you would lose (63.00) from holding Travere Therapeutics or give up 3.2% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Intel  vs.  Travere Therapeutics

 Performance 
       Timeline  
Intel 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Intel are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of rather fragile basic indicators, Intel exhibited solid returns over the last few months and may actually be approaching a breakup point.
Travere Therapeutics 

Risk-Adjusted Performance

21 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Travere Therapeutics are ranked lower than 21 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, Travere Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Intel and Travere Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Intel and Travere Therapeutics

The main advantage of trading using opposite Intel and Travere Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Intel position performs unexpectedly, Travere Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Travere Therapeutics will offset losses from the drop in Travere Therapeutics' long position.
The idea behind Intel and Travere Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Other Complementary Tools

Bonds Directory
Find actively traded corporate debentures issued by US companies
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios